 | • レポートコード：QYR2104Z0302 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ALS）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リルゾール、エダラボン（ラジカバ）、CoQ10、ブチルフタリド、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・筋萎縮性側索硬化症（ALS）治療薬の市場動向 ・企業の競争状況、市場シェア ・筋萎縮性側索硬化症（ALS）治療薬の種類別市場規模（リルゾール、エダラボン（ラジカバ）、CoQ10、ブチルフタリド、その他） ・筋萎縮性側索硬化症（ALS）治療薬の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・筋萎縮性側索硬化症（ALS）治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・筋萎縮性側索硬化症（ALS）治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・筋萎縮性側索硬化症（ALS）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・筋萎縮性側索硬化症（ALS）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・筋萎縮性側索硬化症（ALS）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Mitsubishi Tanabe Pharma、Mylan、Apotex、Glemark Generics、Sun Pharma、Covis Pharma、Lunan Pharma、CSPC Pharmaceutical、Ascend Laboratories、EISAI） ・結論 |
Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmental factors such as exposure to toxic or infectious agents, viruses, physical trauma, diet, and behavioral and occupational factors.
Amyotrophic Lateral Sclerosis Drugs includes Riluzole, Edaravone (Radicava), CoQ10, Baclofen, Butylphthalide and Others. These drugs prolong amyotrophic lateral sclerosis (ALS) survival and slow the disease’s progression in some people. Currently, only riluzole and edaravone have been approved for the treatment of ALS.
Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis Drugs Market
The global Amyotrophic Lateral Sclerosis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Amyotrophic Lateral Sclerosis Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Amyotrophic Lateral Sclerosis Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Amyotrophic Lateral Sclerosis Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Amyotrophic Lateral Sclerosis Drugs market.
Global Amyotrophic Lateral Sclerosis Drugs Scope and Market Size
Amyotrophic Lateral Sclerosis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Riluzole
Edaravone (Radicava)
CoQ10
Butylphthalide
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi
Mitsubishi Tanabe Pharma
Mylan
Apotex
Glemark Generics
Sun Pharma
Covis Pharma
Lunan Pharma
CSPC Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Riluzole
1.2.3 Edaravone (Radicava)
1.2.4 CoQ10
1.2.5 Butylphthalide
1.2.6 Others
1.3 Market by Application
1.3.1 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Perspective (2016-2027)
2.2 Amyotrophic Lateral Sclerosis Drugs Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Amyotrophic Lateral Sclerosis Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Amyotrophic Lateral Sclerosis Drugs Industry Dynamic
2.3.1 Amyotrophic Lateral Sclerosis Drugs Market Trends
2.3.2 Amyotrophic Lateral Sclerosis Drugs Market Drivers
2.3.3 Amyotrophic Lateral Sclerosis Drugs Market Challenges
2.3.4 Amyotrophic Lateral Sclerosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Revenue
3.1.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Revenue (2016-2021)
3.1.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Drugs Revenue
3.4 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio
3.4.1 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Drugs Revenue in 2020
3.5 Amyotrophic Lateral Sclerosis Drugs Key Players Head office and Area Served
3.6 Key Players Amyotrophic Lateral Sclerosis Drugs Product Solution and Service
3.7 Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Amyotrophic Lateral Sclerosis Drugs Breakdown Data by Type
4.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Type (2016-2021)
4.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2022-2027)
5 Amyotrophic Lateral Sclerosis Drugs Breakdown Data by Application
5.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Application (2016-2021)
5.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size (2016-2027)
6.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type
6.2.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021)
6.2.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027)
6.2.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2027)
6.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application
6.3.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021)
6.3.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027)
6.3.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2027)
6.4 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country
6.4.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021)
6.4.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size (2016-2027)
7.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type
7.2.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021)
7.2.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027)
7.2.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2027)
7.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application
7.3.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021)
7.3.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027)
7.3.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2027)
7.4 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country
7.4.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021)
7.4.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size (2016-2027)
8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type
8.2.1 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application
8.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region
8.4.1 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size (2016-2027)
9.2 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type
9.2.1 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2027)
9.3 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application
9.3.1 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2027)
9.4 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country
9.4.1 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size (2016-2027)
10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type
10.2.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application
10.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country
10.4.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Introduction
11.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Mitsubishi Tanabe Pharma
11.2.1 Mitsubishi Tanabe Pharma Company Details
11.2.2 Mitsubishi Tanabe Pharma Business Overview
11.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.2.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
11.2.5 Mitsubishi Tanabe Pharma Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Introduction
11.3.4 Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Apotex Business Overview
11.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Introduction
11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
11.4.5 Apotex Recent Development
11.5 Glemark Generics
11.5.1 Glemark Generics Company Details
11.5.2 Glemark Generics Business Overview
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Introduction
11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
11.5.5 Glemark Generics Recent Development
11.6 Sun Pharma
11.6.1 Sun Pharma Company Details
11.6.2 Sun Pharma Business Overview
11.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.6.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
11.6.5 Sun Pharma Recent Development
11.7 Covis Pharma
11.7.1 Covis Pharma Company Details
11.7.2 Covis Pharma Business Overview
11.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.7.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
11.7.5 Covis Pharma Recent Development
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Details
11.8.2 Lunan Pharma Business Overview
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
11.8.5 Lunan Pharma Recent Development
11.9 CSPC Pharmaceutical
11.9.1 CSPC Pharmaceutical Company Details
11.9.2 CSPC Pharmaceutical Business Overview
11.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Introduction
11.9.4 CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
11.9.5 CSPC Pharmaceutical Recent Development
11.10 Ascend Laboratories
11.10.1 Ascend Laboratories Company Details
11.10.2 Ascend Laboratories Business Overview
11.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Introduction
11.10.4 Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
11.10.5 Ascend Laboratories Recent Development
11.11 EISAI
11.11.1 EISAI Company Details
11.11.2 EISAI Business Overview
11.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Introduction
11.11.4 EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
11.11.5 EISAI Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Riluzole
Table 3. Key Players of Edaravone (Radicava)
Table 4. Key Players of CoQ10
Table 5. Key Players of Butylphthalide
Table 6. Key Players of Others
Table 7. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions (2016-2021)
Table 11. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions (2022-2027)
Table 13. Amyotrophic Lateral Sclerosis Drugs Market Trends
Table 14. Amyotrophic Lateral Sclerosis Drugs Market Drivers
Table 15. Amyotrophic Lateral Sclerosis Drugs Market Challenges
Table 16. Amyotrophic Lateral Sclerosis Drugs Market Restraints
Table 17. Global Amyotrophic Lateral Sclerosis Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Players (2016-2021)
Table 19. Global Top Amyotrophic Lateral Sclerosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2020)
Table 20. Ranking of Global Top Amyotrophic Lateral Sclerosis Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Amyotrophic Lateral Sclerosis Drugs Product Solution and Service
Table 24. Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Amyotrophic Lateral Sclerosis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi Amyotrophic Lateral Sclerosis Drugs Product
Table 67. Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Mitsubishi Tanabe Pharma Company Details
Table 70. Mitsubishi Tanabe Pharma Business Overview
Table 71. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product
Table 72. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
Table 73. Mitsubishi Tanabe Pharma Recent Development
Table 74. Mylan Company Details
Table 75. Mylan Business Overview
Table 76. Mylan Amyotrophic Lateral Sclerosis Drugs Product
Table 77. Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
Table 78. Mylan Recent Development
Table 79. Apotex Company Details
Table 80. Apotex Business Overview
Table 81. Apotex Amyotrophic Lateral Sclerosis Drugs Product
Table 82. Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
Table 83. Apotex Recent Development
Table 84. Glemark Generics Company Details
Table 85. Glemark Generics Business Overview
Table 86. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product
Table 87. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
Table 88. Glemark Generics Recent Development
Table 89. Sun Pharma Company Details
Table 90. Sun Pharma Business Overview
Table 91. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product
Table 92. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
Table 93. Sun Pharma Recent Development
Table 94. Covis Pharma Company Details
Table 95. Covis Pharma Business Overview
Table 96. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product
Table 97. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
Table 98. Covis Pharma Recent Development
Table 99. Lunan Pharma Company Details
Table 100. Lunan Pharma Business Overview
Table 101. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
Table 102. Lunan Pharma Recent Development
Table 103. CSPC Pharmaceutical Company Details
Table 104. CSPC Pharmaceutical Business Overview
Table 105. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product
Table 106. CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
Table 107. CSPC Pharmaceutical Recent Development
Table 108. Ascend Laboratories Company Details
Table 109. Ascend Laboratories Business Overview
Table 110. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product
Table 111. Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
Table 112. Ascend Laboratories Recent Development
Table 113. EISAI Company Details
Table 114. EISAI Business Overview
Table 115. EISAI Amyotrophic Lateral Sclerosis Drugs Product
Table 116. EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
Table 117. EISAI Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Type: 2020 VS 2027
Figure 2. Riluzole Features
Figure 3. Edaravone (Radicava) Features
Figure 4. CoQ10 Features
Figure 5. Butylphthalide Features
Figure 6. Others Features
Figure 7. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Amyotrophic Lateral Sclerosis Drugs Report Years Considered
Figure 12. Global Amyotrophic Lateral Sclerosis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Amyotrophic Lateral Sclerosis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions (2022-2027)
Figure 16. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Players in 2020
Figure 17. Global Top Amyotrophic Lateral Sclerosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue in 2020
Figure 19. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2016-2027)
Figure 23. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2016-2027)
Figure 24. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2016-2027)
Figure 25. United States Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2016-2027)
Figure 29. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2016-2027)
Figure 30. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2016-2027)
Figure 31. Germany Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Share by Region (2016-2027)
Figure 41. China Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2016-2027)
Figure 49. Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2016-2027)
Figure 50. Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2016-2027)
Figure 51. Mexico Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2016-2027)
Figure 57. Turkey Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
Figure 61. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
Figure 62. Mylan Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
Figure 63. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
Figure 64. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
Figure 65. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
Figure 66. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
Figure 67. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
Figure 68. CSPC Pharmaceutical Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
Figure 69. Ascend Laboratories Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
Figure 70. EISAI Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場規模・現状・予測（2021年-2027年） Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune resp…- 世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場規模・現状・予測（2021年-2027年） Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune resp…
- 世界の筋萎縮性側索硬化症（ALS）治療市場規模・現状・予測（2021年-2027年） Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmenta…
- 世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…
- 世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…